T. Gordi

发表

Drug discovery and development: lessons from an undeveloped drug

T. Gordi, 2012, Expert review of clinical pharmacology.

Integrated population pharmacokinetics of etirinotecan pegol and its four metabolites in cancer patients with solid tumors

Y. Chia, U. Hoch, S. Sy, 2018, Cancer Chemotherapy and Pharmacology.

Regadenoson Pharmacokinetics and Tolerability in Subjects With Impaired Renal Function

B. Blackburn, T. Gordi, H. Lieu, 2007, Journal of clinical pharmacology.

A Population Pharmacokinetic/Pharmacodynamic Analysis of Regadenoson, an Adenosine A2A-Receptor Agonist, in Healthy Male Volunteers

L. Belardinelli, A. Wolff, T. Gordi, 2006, Clinical pharmacokinetics.

Translational Pharmacokinetic/Pharmacodynamic Analysis of MYO‐029 Antibody for Muscular Dystrophy

I. Bhattacharya, J. Bosley, T. Gordi, 2016, Clinical and translational science.

CYP3A and P‐Glycoprotein Activity Induction With St. John's Wort in Healthy Volunteers From 6 Ethnic Populations

Amarnath Sharma, E. Antal, D. Nickens, 2005, Journal of clinical pharmacology.

Regadenoson, a selective A2A adenosine receptor agonist, causes dose-dependent increases in coronary blood flow velocity in humans

R. Kerensky, J. Shryock, L. Belardinelli, 2007, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.

Artemisinin derivatives: toxic for laboratory animals, safe for humans?

T. Gordi, E. Lepist, 2004, Toxicology letters.

Clinical Pharmacokinetics of the Antimalarial Artemisinin Based on Saliva Sampling

T. Gordi, 2001 .

Steady-State Pharmacokinetics of Gabapentin after Administration of a Novel Gastroretentive Extended-Release Formulation in Postmenopausal Women with Vasomotor Symptoms

T. Gordi, V. Cowles, S. Hou, 2012, Clinical Drug Investigation.

Artemisinin kinetics and dynamics during oral and rectal treatment of uncomplicated malaria

L. Cong, M. Ashton, T. Gordi, 1998, Clinical pharmacology and therapeutics.

Clinical development of metformin extended-release tablets for type 2 diabetes: an overview

T. Gordi, V. Cowles, M. Cramer, 2008, Expert opinion on drug metabolism & toxicology.

Direct analysis of artemisinin in plasma and saliva using coupled-column high-performance liquid chromatography with a restricted-access material pre-column.

D. Westerlund, M. Ashton, T. Gordi, 2000, Journal of chromatography. B, Biomedical sciences and applications.

Semi-mechanistic pharmacokinetic/pharmacodynamic modelling of the antimalarial effect of artemisinin.

W. Jusko, R. Xie, T. Gordi, 2005, British journal of clinical pharmacology.

Response to the Letter to the Editor by Stephen Toovey and Andrew Jamieson

T. Gordi, E. Lepist, 2004 .

Artemisinin Pharmacokinetics and Efficacy in Uncomplicated-Malaria Patients Treated with Two Different Dosage Regimens

M. Ashton, T. Gordi, T. N. Hai, 2002, Antimicrobial Agents and Chemotherapy.

Artemisinin pharmacokinetics in healthy adults after 250, 500 and 1000 mg single oral doses

L. Cong, M. Ashton, M. Johansson, 1998, Biopharmaceutics & drug disposition.

Pharmacokinetics of gabapentin after a single day and at steady state following the administration of gastric-retentive- extended-release and immediate-release tablets: a randomized, open-label, multiple-dose, three-way crossover, exploratory study in healthy subjects.

T. Gordi, S. Kasichayanula, B. Berner, 2008, Clinical therapeutics.

Simple solution to a common statistical problem: interpreting multiple tests.

H. Khamis, T. Gordi, Toufigh Gordi, 2004, Clinical therapeutics.

The Pharmacokinetics of Linezolid Are Not Affected by Concomitant Intake of the Antioxidant Vitamins C and E

J. G. Slatter, E. Antal, T. Gordi, 2003, Journal of clinical pharmacology.

Population pharmacokinetics of chloroquine and sulfadoxine and treatment response in children with malaria: suggestions for an improved dose regimen.

U. Hellgren, L. Gustafsson, C. Obua, 2008, British journal of clinical pharmacology.

Introduction: Utility of Mathematical Models in Drug Development and Delivery

T. Gordi, B. Berner, 2021, Drug Delivery Approaches.

Population Pharmacokinetics of Boosted‐Elvitegravir in HIV‐Infected Patients

Lijie Zhong, S. Ramanathan, T. Gordi, 2016, Journal of clinical pharmacology.

A semiphysiological pharmacokinetic model for artemisinin in healthy subjects incorporating autoinduction of metabolism and saturable first-pass hepatic extraction.

Mats O Karlsson, M. Karlsson, M. Ashton, 2005, British journal of clinical pharmacology.

Retrospective analysis of artemisinin pharmacokinetics: application of a semiphysiological autoinduction model.

T. Gordi, S. Asimus, 2007, British journal of clinical pharmacology.

Artemisinin pharmacokinetics in healthy adults after 250, 500 and 1000 mg single oral doses

L. Cong, M. Ashton, M. Johansson, 1998, Biopharmaceutics & drug disposition.

Artemisinin derivatives with long elimination half‐life

T. Gordi, 2008 .

Population pharmacokinetics of chloroquine and sulfadoxine and treatment response in children with malaria: suggestions for an improved dose regimen.

U. Hellgren, L. Gustafsson, C. Obua, 2008, British journal of clinical pharmacology.

Steady-state pharmacokinetics of gabapentin after administration of a novel gastroretentive extended-release formulation in postmenopausal women with vasomotor symptoms.

T. Gordi, V. Cowles, S. Hou, 2012, Clinical drug investigation.

Use of saliva and capillary blood samples as substitutes for venous blood sampling in pharmacokinetic investigations of artemisinin

M. Ashton, T. Gordi, T. N. Hải, 2000, European Journal of Clinical Pharmacology.